; and (C) identification of necessary resources from agencies and Congress to accomplish the primary missions under subsection (d). (2) Brief required Not later than 90 days after date of enactment of this Act, and annually thereafter, the Director of the National Center shall provide a brief to Congress on the report required under paragraph (1). (d) Primary missions The primary missions of the National Center shall be as follows: (1) To serve as the primary organization in the United States Government for analyzing, tracking, and halting the movement of synthetic drugs domestically, particularly as it relates to the trafficking of fentanyl, fentanyl analogues, and precursor chemicals to produce fentanyl. (2) To serve as the primary organization in the United States Government for tracking the movements of persons trafficking in the synthetic drug trade in the United States and overseas through intelligence gathering, in cooperation with other agencies, including: (A) The Drug Enforcement Administration. (B) The Department of Justice. (C) The Department of State. (D) The Federal Bureau of Investigations. (E) The Internal Revenue Service. (F) The Department of the Treasury. (G) The National Security Agency. (H) The Central Intelligence Agency. (I) The United States Postal Service. (J) The Department of Homeland Security. (K) The United States Customs and Border Patrol. (L) The Office of National Drug Control Policy. (M) The Office of the Director of National Intelligence. (3) To collect and share information with the agencies identified under paragraph (2) to identify and disrupt the movement of fentanyl from an original source to a consumer. (4) To develop a strategic plan to lead agencies, as appropriate, in the execution of efforts to break up the synthetic drug trade, including assigning roles and responsibilities to such agencies. (5) To ensure that agencies, as appropriate, have access to and receive information from other agencies, needed to execute their efforts to break up the synthetic drug trade or